Insider trades
Ashley Cordova, CEO of NovoCure NVCR, has filed 1 purchase and 14 sales on the open market. The latest trade was on 03/04.
Ashley Cordova
Former CEO
- Company
- NovoCure NVCR
- First filing
- 23/03/02
- Trades
- 40 trades
- Buys / sales
- 1 / 14
- 12-month net buying
- No record
- Last trade
- 03/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NovoCureNVCR | Open-market buy | 25/09/05 | 25/09/08 | 81,550 sh | $12.22 | $996,541 | +22.9% |
NovoCureNVCR | Open-market sale | 25/03/03 | 25/03/04 | 2,053 sh | $18.54 | $38,062.62 | −1.0% |
NVCR | Open-market saleAmendment | 25/02/27–25/02/28 | 25/03/03 | 26,988 sh6 trades | $19.72avg. | $532,200.56 | −11.6% |
NovoCureNVCR | Open-market sale | 24/08/02 | 24/08/05 | 688 sh | $20.14 | $13,856.32 | −0.3% |
NovoCureNVCR | Open-market sale | 23/09/01 | 23/09/05 | 883 sh | $21.82 | $19,267.06 | −0.9% |
NovoCureNVCR | Open-market sale | 23/08/02 | 23/08/04 | 1,144 sh | $30.25 | $34,606 | −1.1% |
NVCR | Open-market sale | 23/03/03 | 23/03/07 | 5,505 sh2 trades | $76.16avg. | $419,260.8 | −5.2% |
NovoCureNVCR | Open-market sale | 23/03/02 | 23/03/06 | 1,055 sh | $75.28 | $79,420.4 | −1.1% |
NovoCureNVCR | Open-market sale | 23/03/01 | 23/03/02 | 2,198 sh | $76.36 | $167,839.28 | −2.2% |